118(Pt 10): p. 2143- 53. 38. Wahl, S.M., J. Wen, et al., TGF -beta: a mobile purveyor of immune privilege. Immunol Rev, 2006. 213: p. 213 -27. 39. Grau, A.M., W. Wen, et al., Circulating transforming growth factor -beta- 1 and breast cancer prognosis: results from the Shanghai Breast Cancer Study . Breast Cancer Res Treat, 2008. 112(2): p. 335 - 41. 40. Ono, Y., T. Hayashida, et al., Direct inhibition of the transforming growth factor -beta pathway by protein- bound polysaccharide through inactivation of Smad2 signaling . Cancer Sci, 2012. 103(2): p. 317 -24. 41. Metzger -Filho, O., E.P. Winer, et al., Pertuzumab: optimizing HER2 blockade. Clin Cancer Res, 2013. 19(20): p. 5552 -6. 42.